...
首页> 外文期刊>Clinical Science >Regulation of plasma LDL: the apoB paradigm
【24h】

Regulation of plasma LDL: the apoB paradigm

机译:血浆LDL的调节:apoB范例

获取原文
获取原文并翻译 | 示例

摘要

The objectives of this analysis are to re-examine the foundational studies of the in vivo metabolism of plasma LDL (low-density lipoprotein) particles in humans and, based on them, to reconstruct our understanding of the governance of the concentration of plasma LDL and the maintenance of cholesterol homoeostasis in the hepatocyte. We believe that regulation of cholesterol homoeostasis within the hepatocyte is demonstrably more complex than envisioned by the LDL receptor paradigm, the conventional model to explain the regulation of plasma LDL and the fluxes of cholesterol into the liver, a model which was generated in the fibroblast but has never been fully validated in the hepatocyte. We suggest that the LDL receptor paradigm should be reconfigured as the apoB (apolipoprotein B) paradigm, which states that the rate at which LDL particles are produced is at least an important determinant of their concentration in plasma as the rate at which they are cleared from plasma and that secretion of cholesterol within VLDL (very-low-density lipoprotein) particles is an important mechanism of maintaining cholesterol homoeostasis within the hepatocyte. These two paradigms are not mutually exclusive. The LDL receptor paradigm, however, includes only one critical aspect of the regulation of plasma LDL, namely the rate at which LDL particles are cleared through the LDL receptor pathway, but ignores another - the rate at which LDL particles are added to the plasma compartment. The apoB paradigm includes both and points to a different model of how the hepatocyte achieves cholesterol homoeostasis in a complex metabolic environment. ,
机译:该分析的目的是重新审查人类血浆LDL(低密度脂蛋白)颗粒的体内代谢的基础研究,并在此基础上重新构建我们对血浆LDL和LDL浓度控制的理解。维持肝细胞中胆固醇的稳态。我们认为,肝细胞内胆固醇稳态的调节比LDL受体范式所设想的要复杂得多,LDL受体范式是解释血浆LDL和胆固醇进入肝脏的通量的传统模型,该模型是在成纤维细胞中产生的,但从未在肝细胞中得到充分验证。我们建议应将LDL受体范式重新配置为apoB(载脂蛋白B)范式,该范式指出,产生LDL颗粒的速率至少是其血浆浓度的重要决定因素,因为它们从血浆中清除的速率血浆和超低密度脂蛋白(VLDL)颗粒内胆固醇的分泌是维持肝细胞内胆固醇同质化的重要机制。这两种范式不是互相排斥的。但是,LDL受体范例仅包括血浆LDL调节的一个关键方面,即通过LDL受体途径清除LDL颗粒的速率,而忽略了另一个-将LDL颗粒添加至血浆室的速率。 apoB范式既包括又指出了在复杂的代谢环境中肝细胞如何实现胆固醇稳态的不同模型。 ,

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号